Effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist, and an endothelin receptor antagonist on renal afferent arteriolar structure

Hypertension

Volumn 28, Issue 3, 1996, Pages 464-471

  Skov, Karin ^a,b   Fenger Grøn, Jesper ^b   Mulvany, Michael J ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

angiotensin converting enzyme inhibitors; arterioles; bosentan; calcium antagonists; kidney; rats, inbred SHR

Indexed keywords

BOSENTAN; CALCIUM ANTAGONIST; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; MIBEFRADIL; NITRENDIPINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; ESSENTIAL HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029823912     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.464     Document Type: Article

References (62)

1. Van Hooft IM, Grobbee DE, Derkx FH, de Leeuw PW, Schalekamp MA, Hofman A. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med. 1991; 324:1305-1311.
2. Guidi E, Bianchi G, Rivolta E, Ponticelli C, Quarto di Palo F, Minetti L, Polli E. Hypertension in man with a kidney transplant: role of familial versus other factors. Nephron. 1985;41:14-21.
3. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethelm AG. Remission of essential hypertension after renal transplantation. N Engl J Med. 1983;309:1009-1015.
4. Bianchi G, Fox U, Di Francesco GF, Giovanetti AM, Pagetti D. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med. 1974;47:435-448.
5. Rettig R, Stauss H, Folberth C, Ganten D, Waldherr B, Unger T. Hypertension transmitted by kidneys from stroke-prone spontaneously hypertensive rats. Am J Physiol. 1989;257:F197-F203.
6. Harrap SB, Doyle AE. Renal haemodynamics and total body sodium in immature spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens Suppl. 1986;4:S249-S252.
7. Dilley JR, Stier CT Jr, Arendshorst WJ. Abnormalities in glomerular function in rats developing spontaneous hypertension. Am J Physiol. 1984;246:F12-F20.
8. Gattone VH, Evan AP, Willis LR, Luft FC. Renal afferent arteriole in the spontaneously hypertensive rat. Hypertension. 1983;5:8-16.
9. Hsu CH, Slavicek JH, Kurtz TW. Segmental renal vascular resistance in the spontaneously hypertensive rat. Am J Physiol. 1982;242:H961-H966.
10. Kimura K, Tojo A, Matsuoka H, Sugimoto T. Renal arteriolar diameters in spontaneously hypertensive rats: vascular cast study. Hypertension. 1991;18:101-110.
11. Skov K, Mulvany MJ, Korsgaard N. Morphology of renal afferent arterioles in spontaneously hypertensive rats. Hypertension. 1992; 20:821-827.
12. Gebremedhin D, Fenoy FJ, Harder DR, Roman RJ. Enhanced vascular tone in the renal vasculature of spontaneously hypertensive rats. Hypertension. 1990;16:648-654.
13. Norrelund H, Christensen KL, Samani NJ, Kimber P. Mulvany MJ, Korsgaard N. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension. 1994; 24:301-308.
14. Harrap SB, Nicolaci JA, Doyle AE. Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril. Clin Exp Pharmacol Physiol. 1986;13:753-765.
15. Notoya M, Nakamura M, Mizojiri K. Effects of lisinopril on the structure of renal arterioles. Hypertension. 1996;27:364-370.
16. Loutzenhiser RD, Epstein M. Calcium antagonists and the kidney. Am J Hypertens. 1989;2:1545-1615.
17. Kimura K, Tojo A, Hirata Y, Hayakawa H, Goto A, Omata M. Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles. Blood Press Suppl. 1994;5:71-74.
18. Fischli W, Hefti F, Clozel JP. Effects of acute and chronic cilazapril treatment in spontaneously hypertensive rats. Br J Clin Pharmacol, 1989;27(suppl 2):151S-158S.
19. Benstein JA, Dworkin LD. Renal vascular effects of calcium channel blockers in hypertension. Am J Hypertens. 1990;3:305S-312S.
20. Epstein M. Calcium antagonists and the kidney: implications for renal protection. Am J Hypertens. 1993;6:251S-259S.
21. Harashima H, Kiwada H, Kajita J, Kobayashi S. Effects of benidipine hydrochloride (Coniel), a new calcium antagonist, on the cardiac output, regional blood flow and vascular resistance in conscious, spontaneously hypertensive rats. Biopharm Drug Dispos. 1994;15: 431-438.
22. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and smallartery structure. Hypertension. 1994;23:659-666.
23. Clozel JP, Kuhn H, Hefti F. Decreases of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats. Am J Med. 1989;87:92S-95S.
24. Nyborg NC, Mulvany MJ. Lack of effect of anti-hypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Cardiovasc Res. 1985;19:528-536.
25. Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens. 1989; 7:83-90.
26. Ferrante F, Abbate F, Ciriaco E, Laura R, Amenta F. Influence of isradipine treatment on the morphology of the aorta in spontaneously hypertensive rats. J Hypertens. 1994;12:523-531.
27. Giudicelli JF, Freslon JL, Glasson S, Richer C. Captopril and hypertension development in the SHR. Clin Exp Hypertens. 1980;2:1083-1096.
28. Wu JN, Berecek KH. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension. 1993;22: 139-146.
29. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti Rosei E. Delayed development of hypertension after short-term nitrendipine treatment. Hypertension. 1994;24:131-139.
30. Kato T, Kassab S, Wilkins FC Jr, Kirchner KA, Keiser J, Granger JP. Endothelin antagonists improve renal function in spontaneously hypertensive rats. Hypertension. 1995;25:883-887.
31. Hocher B, Rohmeiss P, Zart R, Diekmann F, Vogt V, Metz D, Fakhury M, Gretz N. Bauer C, Koppenhagen K, Distler A. Significance of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats: renal and haemodynamic effects of endothelin receptor antagonists. J Cardiovasc Pharmacol. 1995;26 (suppl 3):s470-s472.
32. Li JS, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension. 1995;25:495-500.
33. Bird JE, Moreland S, Waldron TL, Powell JR. Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension. 1995;25:1191-1195.
34. Faarup P. Morphological Aspects of the Renin-Angiotensin System. Aarhus. Denmark: University of Aarhus: 1971:13-31. Thesis.
35. Rosenthal JH. Therapeutic experience with cilazapril. J Cardiovasc Pharmacol. 1994;24(suppl 2):S65-S69.
36. Veniant M, Clozel JP, Heudes D, Banken L, Menard J. Effects of Ro 40-5967. a new calcium antagonist, and enalapril on cardiac remodeling in renal hypertensive rats. J Cardiovasc Pharmacol. 1993; 21:544-551.
37. Schmitt R, Kleinbloesem CH, Belz GG, Schroeter V, Feifel U, Pozenel H, Kirch W, Halabi A, Woittiez AJ, Welker HA, van Brummelen P. Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension. Clin Pharmacol Ther. 1992;52:314-323.
38. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate - salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension. 1994;24:183-188.
39. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
40. Schmid Schonbein GW, Firestone G, Zweifach BW. Network anatomy of arteries feeding the spinotrapezius muscle in normotensive and hypertensive rats. Blood Vessels. 1986;23:34-49.
41. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev. 1990;70:921-961.
42. Smeda JS, Lee RM, Forrest JB. Structural and reactivity alterations of the renal vasculature of spontaneously hypertensive rats prior to and during established hypertension. Circ Res. 1988;63:518-533.
43. Skov K, Nyengaard JR, Korsgaard N, Mulvany MJ. Number and size of renal glomeruli in spontaneously hypertensive rats. J Hypertens. 1994;12:1373-1376.
44. Berecek KH, Schwertschlag U, Gross F. Alterations in renal vascular resistance and reactivity in spontaneous hypertension of rats. Am J Physiol. 1980;238:H287-H293.
45. Gothberg G, Lundin S, Ricksten SE, Folkow B. Apparent and true vascular resistances to flow in SHR and NCR kidneys as related to the pre/postglomerular resistance ratio. Acta Physiol Scand. 1979; 105:282-294.
46. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension. 1993;21:391-397.
47. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
48. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13:968-972.
49. Lee RM, Berecek KH, Tsoporis J, McKenzie R, Triggle CR. Prevention of hypertension and vascular changes by captopril treatment. Hypertension. 1991;17:141-150.
50. Korner PI, Bobik A. Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1995;25:610-619.
51. Shimamoto H, Shimamoto Y. Lisinopril improves aortic compliance and renal flow: comparison with nifedipine. Hypertension. 1995; 25:327-334.
52. Numabe A, Komatsu K, Frohlich ED. Effects of ANG-converting enzyme and alpha 1-adrenoceptor inhibition on intrarenal hemodynamics in SHR. Am J Physiol. 1994;266:R1437-R1442.
53. Komatsu K, Frohlich ED, Ono H, Ono Y, Numabe A, Willis GW. Glomerular dynamics and morphology of aged spontaneously hypertensive rats: effects of angiotensin-converting enzyme inhibition. Hypenension, 1995;25:207-213.
54. Kett MM, Alcorn D, Bertram JF, Anderson WP. Enalapril does not prevent renal arterial hypertrophy in spontaneously hypertensive rats. Hypertension. 1995;25:335-342.
55. Isshiki T, Nishikimi T, Uchino K, Kardon MB, Frohlich ED. Diltiazem reduces glomerular pressure in spontaneously hypertensive rats. Cardiovasc Drugs Ther: 1992;6:91-92. Letter.
56. Clozel JP. Effects of nitrendipine and cilazapril alone or in combination on hemodynamics and regional blood flows in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1988;12: 600-607.
57. Dworkin LD, Feiner HD, Parker M, Tolbert E. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. Kidney Int. 1991;39:1112-1117.
58. Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD, Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int. 1993;43:808-814.
59. Dworkin LD, Levin RI, Benstein JA, Parker M, Ullian ME, Kim Y, Feiner HD. Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension. Am J Physiol. 1990;259:F598-F604.
60. Campbell DJ, Duncan AM, Kladis A, Harrap SB. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1995;26:426-436.
61. Christe ME, Perretta AA, Li P, Capasso JM, Anversa P, Rodgers RL. Cilazapril treatment depresses ventricular function in spontaneously hypertensive rats. Am J Physiol. 1994;267:H2050-H2057.
62. Oozel JP, Hefti F. Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1988;11: 568-572.